$45.39
+1.54 (+3.51%)
At Close: Jun 22, 2026
Ipsen S.A. (IPSEY) Discusses Phase II LANTIC Data and Innovation in Engineered Neuroinhibitors for Aesthetic Indications Transcript
Annual General Meeting of Ipsen S.A. held on 13 May 2026
12:15pm, Wednesday, 13'th May 2026
Annual General Meeting of Ipsen S.A. held on 13 May 2026 All the resolutions submitted to the shareholders' vote have been adopted PARIS, FRANCE, 13 MAY 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) annou
Ipsen S.A. – Evolution of the composition of the Board of Directors
12:15pm, Wednesday, 13'th May 2026
Ipsen S.A. – Evolution of the composition of the Board of Directors PARIS, FRANCE, 13 MAY 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today that Mrs. Karen Witts has resigned from her positio
Ipsen S.A. (IPSEY) Q1 2026 Earnings Call Transcript
11:41am, Thursday, 23'rd Apr 2026
Ipsen S.A. (IPSEY) Q1 2026 Earnings Call Transcript
IPSEN (OTCMKTS:IPSEY) Shares Cross Above Two Hundred Day Moving Average – Should You Sell?
02:10am, Tuesday, 31'st Mar 2026
IPSEN (OTCMKTS:IPSEY - Get Free Report) crossed above its two hundred day moving average during trading on Monday. The stock has a two hundred day moving average of $38.24 and traded as high as $44.00
Ipsen S.A. publishes its 2025 Consolidated Financial Statements
04:26am, Thursday, 19'th Feb 2026
Ipsen S.A. publishes its 2025 Consolidated Financial Statements Attachment Ipsen_Consolidated financial statements 2025_GB
GENFIT to receive US$20M milestone after Ipsen's Iqirvo® exceeds the US$200M threshold in its first full year of net sales
12:35pm, Thursday, 12'th Feb 2026
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), February 12, 2026 - GENFIT (Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients wi
Ipsen S.A. (IPSEY) Q4 2025 Earnings Call Transcript
11:14am, Thursday, 12'th Feb 2026
Ipsen S.A. (IPSEY) Q4 2025 Earnings Call Transcript
IPSEN (OTCMKTS:IPSEY) Shares Gap Up – What’s Next?
02:14am, Friday, 02'nd Jan 2026
IPSEN (OTCMKTS:IPSEY - Get Free Report) gapped up prior to trading on Wednesday. The stock had previously closed at $34.93, but opened at $36.3596. IPSEN shares last traded at $36.3596, with a volume
IPSEN (OTCMKTS:IPSEY) Shares Pass Above Two Hundred Day Moving Average – Time to Sell?
03:28am, Saturday, 20'th Dec 2025
Shares of IPSEN (OTCMKTS:IPSEY - Get Free Report) crossed above its two hundred day moving average during trading on Friday. The stock has a two hundred day moving average of $33.27 and traded as high
IPSEN (OTCMKTS:IPSEY) Shares Pass Above 200 Day Moving Average – What’s Next?
04:02am, Friday, 12'th Dec 2025
IPSEN (OTCMKTS:IPSEY - Get Free Report) crossed above its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of $33.02 and traded as high as $35.55. IPSEN shares
Ipsen S.A. (IPSEY) Q3 2025 Earnings Call Transcript
11:03am, Wednesday, 22'nd Oct 2025
Ipsen S.A. (OTCPK:IPSEY) Q3 2025 Earnings Call October 22, 2025 7:00 AM EDT Company Participants David Loew - MD, CEO & Director Aymeric Le Chatelier - Executive VP & CFO Christelle Huguet - Executive
Ipsen S.A. publishes its 2025 Half-Year Report (half-year ended 30 June 2025)
12:00pm, Thursday, 31'st Jul 2025
Ipsen S.A. publishes its 2025 Half-Year Report (half-year ended 30 June 2025) Attachment 2025 Half-year Financial Report_Ipsen SA
Ipsen S.A. - Initiation of the share buy-back program
01:00am, Monday, 02'nd Jun 2025
Regulated information Ipsen initiates a share buy-back program to cover its free employee share-allocation plan PARIS, FRANCE, 2 June 2025 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today tha
Ipsen S.A. - Annual General Meeting held on 21 May 2025
12:00pm, Wednesday, 21'st May 2025
Annual General Meeting of Ipsen S.A. held on 21 May 2025 All the resolutions submitted to the shareholders' vote have been adopted PARIS, FRANCE, 21 May 2025 - Ipsen (Euronext: IPN; ADR: IPSEY) announ
Sign In
Buy IPSEY